Prazosin Completed Phase 4 Trials for Rhinitis Medicamentosa / Tachyphylaxis / Allergic Rhinitis (AR) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00487032Differential Adrenoreceptor Mediated Tachyphylaxis and Upregulation